LY-367,265
chemical compound
≈ 1 min read
Names in other languages
- EnglishLY-367,265
- shLY-367,265
- СрпскиLY-367,265
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
LY-367,265 is a drug of the tetrahydropyridinylindole group developed by Eli Lilly, which acts as both a potent and selective antagonist at the serotonin 5-HT 2A receptor, and also a selective serotonin reuptake inhibitor (SSRI). It has antidepressant effects in animal studies, reduces glutamate signalling in the brain and increases the analgesic effects of morphine.
See also
Tetrahydropyridinylindole Substituted tryptamine § Related compounds
Text derived from https://en.wikipedia.org/w/index.php?oldid=1338610694 under CC BY-SA 4.0; modifications have been made.